Long‐term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era
Berry JL, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW. Long‐term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era. Pediatric Blood & Cancer 2017, 64 PMID: 28646513, DOI: 10.1002/pbc.26696.Peer-Reviewed Original ResearchConceptsGroup D eyesGroup D retinoblastoma eyesD eyesSystemic chemoreductionIntravitreal melphalanSalvage rateRetinoblastoma eyesIntravitreal melphalan injectionRetrospective chart reviewOverall salvage ratePrimary outcome measurementLong-term outcomesExternal beam radiationOcular salvageSalvage therapyVitreous seedsChart reviewGlobe salvageIntravitreal injectionKaplan-MeierTreatment modalitiesTumor recurrenceMelphalan injectionOutcome measurementsMelphalanClinical Significance of Optic Nerve Enhancement on Magnetic Resonance Imaging in Enucleated Retinoblastoma Patients
Kim JW, Madi I, Lee R, Zolfaghari E, Jubran R, Lee TC, Murphree AL, Berry JL. Clinical Significance of Optic Nerve Enhancement on Magnetic Resonance Imaging in Enucleated Retinoblastoma Patients. Ophthalmology Retina 2017, 1: 369-374. PMID: 31047563, PMCID: PMC7448757, DOI: 10.1016/j.oret.2017.03.013.Peer-Reviewed Original ResearchOptic nerve enhancementAbnormal MRI findingsOptic nerve invasionNerve enhancementOptic nerveMRI scansNerve invasionMRI findingsClinical significanceRetinoblastoma patientsMagnetic resonance imaging (MRI) findingsPostoperative contrast enhancementTransected optic nerveContrast enhancementAbnormal contrast enhancementRetrospective chart reviewPostoperative MRI scansPrimary outcome measureResonance Imaging FindingsLast clinical followRadiographic grading systemMagnetic resonance imagingPostoperative enhancementPreoperative chemotherapyChart reviewTreatment Outcomes of Focal Laser Consolidation during Chemoreduction for Group B Retinoblastoma
Kim JW, Aziz HA, McGovern K, Zolfaghari E, Jubran RF, Murphree AL, Berry JL. Treatment Outcomes of Focal Laser Consolidation during Chemoreduction for Group B Retinoblastoma. Ophthalmology Retina 2017, 1: 361-368. PMID: 31047562, PMCID: PMC7448755, DOI: 10.1016/j.oret.2017.01.014.Peer-Reviewed Original ResearchGlobe salvage rateGroup B tumorsTumor sizeB tumorsChorioretinal scarsSalvage rateTreatment outcomesPosterior fundusSingle-institution retrospective chart reviewScar sizeOverall globe salvage rateInitial laser treatmentMedian percent reductionRetrospective chart reviewGroup B eyesEnd of treatmentVertical diameterOriginal tumor sizeFinal scar sizeAssociation of timingLaser treatmentPerifoveal lesionsSystemic chemoreductionSystemic chemotherapyChart review